vimarsana.com
Home
Live Updates
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline - adhoc - Börsennachrichten : comparemela.com
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline - adhoc - Börsennachrichten
Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to
Related Keywords
Synimmune Gmb ,
Christoph Antz ,
Oliverr Baumann ,
Xlife Sciences ,
Synimmune Gmbh ,
Acute Myeloid Leukemia ,
Acute Myeloid ,
Shareholders Meeting ,
Year Report ,
Ouxlife ,
Ciences ,
Mergers ,
Mp ,
Cquisitionstakeover ,
Eraxa ,
Biotech ,
Cquires ,
Ynimmune ,
Xpand ,
Dancer ,
Pipeline ,
Etcest ,
Release ,
Announcement ,
Ursuant ,
Ssuer ,
Olely ,
Esponsible ,
Content ,
,
comparemela.com © 2020. All Rights Reserved.